Article info

Download PDFPDF
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration
  1. Dr M P Ávila, Centro Brasileiro de Cirurgia de Olhos, CEP 74210-010 Goiânia—Goiás, Brazil; retina{at}cbco.com.br
View Full Text

Citation

Ávila MP, Farah ME, Santos A, et al
Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of subfoveal choroidal neovascularisation secondary to age-related macular degeneration

Publication history

  • Accepted October 22, 2008
  • First published November 19, 2008.
Online issue publication 
February 24, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.